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Summary
The mitochondrial deacetylase SIRT3 regulates several important
metabolic processes. SIRT3 is transcriptionally upregulated in
multiple tissues during nutrient stresses such as dietary restric-
tion and fasting, but the molecular mechanism of this induction is
unclear. We conducted a bioinformatic study to identify tran-
scription factor(s) involved in SIRT3 induction. Our analysis
identified an enrichment of binding sites for nuclear respiratory
factor 2 (NRF-2), a transcription factor known to play a role in the
expression of mitochondrial genes, in the DNA sequences of
SIRT3 and genes with closely correlated expression patterns.
In vitro, knockdown or overexpression of NRF-2 modulated SIRT3
levels, and the NRF-2a subunit directly bound to the SIRT3
promoter. Our results suggest that NRF-2 is a regulator of
SIRT3 expression and may shed light on how SIRT3 is upregulated
during nutrient stress.
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Introduction
The NAD+-dependent mitochondrial deacetylase sirtuin-3 (SIRT3) is
central to the regulation of cellular metabolism, including the adaptation
to nutrient stresses such as fasting and dietary restriction (DR) (Lombard
et al., 2007; Hebert et al., 2013). SIRT3 protein levels are upregulated by
fasting and DR in liver, where it stimulates fatty acid oxidation (Hirschey
et al., 2010) and activates key nodes of ketone body production
(Shimazu et al., 2010) and the urea cycle (Hallows et al., 2011). SIRT3
mRNA levels are also upregulated by DR in brown adipose tissue, where
SIRT3 activates mitochondrial thermogenesis (Shi et al., 2005). In
addition, SIRT3 mediates some of the beneficial effects of DR, such as
the activation of mitochondrial superoxide dismutase to reduce oxidative
stress (Qiu et al., 2010; Tao et al., 2010) and the prevention of age-
related hearing loss in mice (Someya et al., 2010). Conversely, livers of
mice fed a chronic high-fat diet exhibit reduced SIRT3 mRNA and protein
levels (Hirschey et al., 2011), indicating that SIRT3 expression is
dynamically regulated by nutrient intake.
Surprisingly, little is known about the molecular control of SIRT3
expression. In murine adipocytes and hepatocytes, the transcription
factor estrogen-related receptor a (ERRa) has been shown to induce
SIRT3 expression in conjunction with peroxisome proliferator-activated
receptor c coactivator 1-a (PGC-1a) (Kong et al., 2010; Giralt et al.,
2011). In this study, we employed a bioinformatic approach to identify
additional transcription factors which regulate SIRT3 expression. We
searched publicly available microarray data to identify datasets with an
induction of SIRT3 by either DR or fasting and then computationally
identified transcription factor binding motifs enriched in the regulatory
regions of SIRT3 and co-induced genes. Our bioinformatic analysis and
experimental validation in cell culture identified nuclear respiratory factor
2 (NRF-2) as a novel transcriptional regulator of SIRT3 expression.
Results
Bioinformatic analysis
To identify transcription factors involved in SIRT3 induction, we undertook
a systematic bioinformatic approach (Fig. 1A). We first identified datasets
in which SIRT3 mRNA expression was increased with DR in neocortex
(GSE11291; Barger et al., 2008), cochlea (GSE4786, Someya et al., 2007),
and liver (GSE26267, Streeper et al., 2012), and with fasting in kidney
(GSE24504, Hakvoort et al., 2011). We conducted gene set enrichment
analysis (Table S1, Supporting information) to verify that this induction was
part of a larger metabolic adaptation. Next, based on the rationale that co-
expressed genes may share common transcriptional regulators, we
identified the genes most closely co-induced with SIRT3 in each dataset
(Fig. 1B, File S1, Supporting information). Groups of 25, 50, and 100 genes
were analyzed, allowing for greater statistical power than an analysis of
SIRT3 alone. Gene ontology analysis showed that the genes most closely
co-induced with SIRT3 were enriched in metabolism-related annotations,
as well as processes such as the cellular response to stress (Fig. 1C, Table
S2, Supporting information), suggesting that many co-regulated genes are
functionally related to SIRT3. For each dataset, a DNA sequence analysis
algorithm (Warner et al., 2008) was then used to calculate the enrichment
of a set of transcription factor motifs in 20 kbp of sequence surrounding (i)
the most SIRT3-correlated genes overall or (ii) the most SIRT3-correlated
mitochondrial genes (as determined by inclusion in the MitoCarta,
Pagliarini et al., 2008; File S2, Supporting information). The mitochondrial
group was included because SIRT3 is a mitochondrial-localized protein, and
factors which regulate its expression may act specifically on nuclear-
encoded mitochondrial genes during processes induced by nutrient stress
such as mitochondrial biogenesis (e.g., Scarpulla, 2002).
The highest-scoring transcription factor motif identified by this study
was nuclear respiratory factor 2 (NRF-2, also known as GABP) (Rosmarin
et al., 2004) from the neocortex dataset, regardless of number of genes
analyzed (Fig. 1D–F; for the other datasets, Fig. S1 (Supporting
information); full results for all datasets are in File S3, Supporting
information). NRF-2 was also the only motif significantly enriched across
the analyses of 25, 50, and 100 genes (Fig. 1G). NRF-2 is an E26
transformation-specific (ETS) family transcription factor that is important
for the expression of many mitochondrial genes (Scarpulla, 2002). NRF-2
is bound and co-activated by PGC-1a, and it is central to mitochondrial
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biogenesis and metabolism (Mootha et al., 2004; Baldelli et al., 2013).
All ten nuclear-encoded cytochrome c oxidase subunits have functional
NRF-2 binding sites (Ongwijitwat & Wong-Riley, 2005), and recognition
sites for NRF-2 are also present in the promoters of ATP synthase
subunit-b and succinate dehydrogenase subunits B, C, and D (Scarpulla,
2002). The effects of DR/fasting on NRF-2 and its targets in the datasets
studied are included as Fig. S2 (Supporting information). SIRT3 directly
interacts with several components of the electron transport chain,
including ATP synthase subunit b and succinate dehydrogenase subunit
A (Finley et al., 2011; Vassilopoulos et al., 2014), and one of its few
known regulators is PGC-1a. This functional overlap supports our
bioinformatic finding of NRF-2 as a candidate regulator of SIRT3.
Analysis of SIRT3 promoter
To investigate whether NRF-2 regulates SIRT3 expression, we probed for
NRF-2 binding sites in the SIRT3 promoter. SIRT3 shares a short
bidirectional promoter with the 26S proteasome non-ATPase regulatory
subunit 13 (PSMD13) (Bellizzi et al., 2007). The two genes are coded on
opposite strands, with their 50 ends toward each other and < 1 kbp
apart. Because of the bidirectional promoter, any binding sites in the
SIRT3 promoter are also in the PSMD13 promoter. Dissection of the
promoter using a separate sequence analysis tool (MAPPER, http://
genome.ufl.edu/mapper/; Marinescu et al., 2005) identified several
transcription factor binding motifs (Fig. 2A). Notably, NRF-2 was the
only overlap between our significant DNA sequence analysis results for
the neocortex dataset and the MAPPER results (Fig. 2B). Moreover, NRF-
2 sites often occur in tandem (Virbasius & Scarpulla, 1991), and the best-
conserved region of the entire promoter is a pair of NRF-2 consensus
sequences (Fig. 2C). NRF-2 is also known to direct transcription from
many bidirectional promoters (Collins et al., 2007). Taken together with
the motif enrichment results above, our findings strongly suggested that
NRF-2 may play a role in regulating SIRT3 expression, and perhaps
PSMD13 expression as well, via the PSMD13-SIRT3 promoter.
Experimental investigation of NRF-2 and SIRT3
We tested experimentally whether NRF-2 regulates SIRT3 and PSMD13
gene expression using human 293T cells. NRF-2 functions as a
heterodimer, with the a subunit binding DNA and the b subunit
facilitating binding between heterodimers (Batchelor et al., 1998). When
NRF-2a and NRF-2b1 were transiently overexpressed together (Fig. 3A,
B), SIRT3 mRNA levels were significantly induced (P = 0.046 for HA-
tagged NRF-2, P = 0.003 for untagged NRF-2, Fig. 3C) to a greater
degree than known NRF-2 target DNA polymerase subunit c-2 (POLG2)
(P = 0.26 for HA-tagged NRF-2, P = 0.44 for untagged NRF-2, Fig. 3D).
PSMD13 levels were not significantly affected (P = 0.21 for HA-tagged
NRF-2, P = 0.77 for untagged NRF-2, Fig. 3E) and were likewise only
weakly correlated with SIRT3 expression in the four datasets examined
(File S1, Supporting information). Conversely, when the DNA-binding
NRF-2a subunit was knocked down (Fig. 3F), SIRT3 mRNA levels
significantly dropped (P = 0.005, Fig. 3G). These data demonstrate that
SIRT3 expression responded dynamically to NRF-2 levels.
Having identified the presence of canonical NRF-2 binding sites in the
SIRT3 promoter and characterized the response of SIRT3 expression to
NRF-2 overexpression, we next tested whether the response to NRF-2
occurs via the SIRT3 promoter. A luciferase reporter plasmid driven by
the shared promoter in either the SIRT3 or PSMD13 direction (Satter-
strom & Haigis, 2014) was transfected into 293T cells. NRF-2 was then
overexpressed and luminescence measured. Overexpression of NRF-2
increased the activation of the reporter when driven by the SIRT3
promoter (P < 0.01, Fig. 3H) but did not have a significant effect when
the promoter was inserted in the PSMD13 direction (activity decreased,
P = 0.09, Fig. 3I). Further, point mutation or deletion of the NRF-2
binding site greatly reduced the activity of the reporter in the SIRT3
direction (Fig. 3J–K). Together with the quantitative PCR data, these
data suggest that NRF-2 may control SIRT3 expression by direct
interaction with the SIRT3 promoter.
To test physical binding of the SIRT3 promoter by NRF-2, a chromatin
immunoprecipitation was performed in 293T cells transiently overex-
pressing HA-tagged NRF-2a, the DNA-binding subunit of the NRF-2
heterodimer. Following chromatin isolation, HA tag was immunoprecip-
itated and qPCR was used to quantify the levels of target DNA.
Immunoprecipitation and quantification were carried out three times.
Using b-actin as a background normalization factor across experiments,
SIRT3 was significantly enriched in the NRF-2a-treated condition
compared to the untreated condition (P = 0.005). This enrichment was
to approximately the same degree as genes known to be transcription-
ally regulated by NRF-2 (Bruni et al., 2010), such as mitochondrial
transcription termination factor (mTERF) (P = 0.99), mitochondrial RNA
polymerase (POLRMT) (P = 0.30), and mitochondrial transcription factor
B2 (TFB2M) (P = 0.43), and to a significantly greater degree than non-
NRF-2-regulated genes such asmTERF3 (P = 0.01) and ribosomal protein
L30 (RPL30) (P = 0.002) (Fig. 3L). This enhancement was not seen with
control anti-histone H3 immunoprecipitations (Fig. 3M). These results
suggest that NRF-2a physically binds the SIRT3 promoter to affect SIRT3
gene expression.
Discussion
In this study, we have discovered that nuclear respiratory factor 2 (NRF-2)
is a novel regulator of SIRT3 expression. We used a bioinformatic analysis
to show that NRF-2 binding sites are highly enriched in the regulatory
regions of SIRT3 and genes that are similarly induced by DR. We have
also demonstrated that SIRT3 mRNA levels respond to overexpression or
knockdown of NRF-2 in 293T cells and that the same effect occurs when
using a luciferase reporter with the SIRT3 promoter. Finally, we have
shown by chromatin immunoprecipitation that the a subunit of NRF-2
binds the SIRT3 promoter directly, suggesting a model wherein NRF-2
binds the SIRT3 promoter, leading to the expression of SIRT3 mRNA. Our
data also suggest that SIRT3 and PSMD13 are regulated independently,
as NRF-2 induces the expression of SIRT3 but not PSMD13 under the
conditions studied.
NRF-2 binds and is co-activated by PGC-1a, leading to an increase in its
induction of target genes (Mootha et al., 2004; Baldelli et al., 2013).
Notably, ERRa, which is already known to play a role in activating SIRT3
transcription, is also co-activated by PGC-1a (Schreiber et al., 2003). Both
NRF-2 and ERRa drive the expression of oxidative genes as well as each
other (Mootha et al., 2004), but theymay be active at different times or in
different tissues; in support of this idea, NRF-2 was a significant result for
our analysis of the neocortex dataset, while one significant result for our
analysis of the liver dataset was ERRb (which has a nearly identical binding
motif to ERRa; ERRa was not in the set of JASPAR motifs). Although
further study is needed to determine the relative importance of these
transcription factors for the induction of SIRT3 in different physiological
contexts, our data suggest that NRF-2 plays an important role.
Because PGC-1a is induced in certain tissues by fasting or DR (Lehman
et al., 2000), the PGC-1a/NRF-2 pathway may underlie the upregulation
of SIRT3 and other mitochondrial genes in DR. The overlap in pathways
affected by NRF-2 and SIRT3 supports this idea. Even under basal
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conditions, the deletion of NRF-2 in mouse embryonic fibroblasts reduces
many markers of mitochondrial biogenesis, including oxygen consump-
tion and ATP production (Yang et al., 2014). SIRT3, meanwhile, is known
to increase oxygen consumption (Shi et al., 2005), to be important for
ATP production (Ahn et al., 2008), and to be important for mitochondrial
biogenesis (Kong et al., 2010). These functions are enhanced during
(A)
(D)
Examine DR and fasting
microarray datasets
ID datasets with
upregulated SIRT3
Conduct GSEA to
verify metabolic response
Calculate genes
co-expressed with SIRT3
Analyze sequences
for TF motif enrichment
0.50 0.70
Tr
an
sc
ri
pt
io
n 
fa
ct
or
 m
ot
ifs
NRF-2
ELK1
CEBPA
HLTF
FOXQ1
ELK4
GATA2
NFE2L1
PAX2
MZF1
**
**
*
*
*
*
*
(C)(B)
Gene Description                               Correlation
SIRT3 NAD-dependent deacetylase involved in regulation of cellular energy metabolism 1.000
NDUFB3 Accessory subunit to complex I of electron transport chain   0.974
TIPIN DNA damage response, cell cycle progression    0.971
TMEM141 Multi-pass membrane protein     0.964
EDC4 mRNA decapping during mRNA degradation    0.962
SYF2 Splicing of pre-mRNA transcripts     0.960
FAM173A Single-pass membrane protein     0.957
H2AFZ Histone H2A variant      0.956
DAPK2 Kinase which plays a role in cell survival, apoptosis, and autophagy   0.955
PRDX5 Reduces hydroperoxides, involved in redox signaling    0.951
TYW5 tRNA hydroxylase, component of wybutosine biosynthesis pathway  0.951
METTL5 Putative methyltransferase     0.949
NAE1 Component of E1 NEDD8-activating enzyme; able to bind β-amyloid precursor  0.949
PNKP NHEJ and BER pathways of DNA repair     0.948
NAA20 Catalytic subunit of complex which acetylates N-terminal methionine  0.947
APITD1 DNA-binding component of Fanconi Anemia core complex involved in DNA repair  0.947
FGFR1OP Required for anchoring microtubules to the centrosome   0.946
SLC35B3 Transports 3' P-adenosine 5' P-sulfate from cytosol to Golgi lumen   0.944
GRHPR Glyoxylate/hydroxypyruvate reductase and D-glycerate dehydrogenase activity  0.944
MAGOH Core component of multiprotein exon junction complex on mRNAs  0.942
PUS10 Catalyzes isomerization of uridine to pseudouridine in structural RNA  0.942
MPPE1 Required for transport of GPI-anchored proteins from ER to Golgi   0.941
HSD11B1 Interconverts cortisone and cortisol     0.940
CHRAC1 Binds DNA for packing into chromatin     0.940
CCZ1 Lysosomal membrane protein     0.940
Gene Ontology Term       Corrected P Value
Metabolic Process  2.60E-06
Intracellular   6.19E-05
Catalytic Activity  7.85E-05
Membrane-Bounded Organelle 7.85E-05
Oxidoreductase Activity  4.57E-03
Primary Metabolic Process  1.23E-02
Catabolic Process  1.41E-02
Proteasome Core Complex 1.43E-02
Threonine-Type Endopeptidase Activity 1.43E-02
RNA Processing  1.43E-02
RNA Metabolic Process  1.43E-02
Macromolecule Metabolic Process 1.43E-02
NADH Dehydrogenase Activity 1.43E-02
Spliceosomal Complex  1.81E-02
NADP or NADPH Binding  1.98E-02
NAD or NADH Binding  2.79E-02
N-Acetyltransferase Activity 2.79E-02
Acyltransferase Activity  2.79E-02
Endopeptidase Activity  2.79E-02
Nitrogen Compound Metabolic Process 2.79E-02
Cell Redox Homeostasis  3.19E-02
Nucleic Acid Metabolic Process 3.19E-02
Respiratory Chain  3.20E-02
Cellular Response to Stress 3.57E-02
Cofactor Binding  3.95E-02
AUC statistic
Experimentally test
bioinformatic prediction
(G)
0.50 0.75
NRF-2
NR2E3
PAX2
CEBPA
NR4A2
BRCA1
HLTF
ELK4
MYC-MAX
n-MYC
**
**
AUC statistic
0.50 0.65
NRF-2
ELK1
ELK4
FOXC1
HLTF
FEV
PAX2
GATA2
NR2E3
CEBPA
**
**
**
**
*
*
AUC statistic
*
(E) (F)
NRF-2 ELK1
ELK4
CEBPA
PAX2
HLTF
FOXQ1
GATA2
FOXC1
FEV
MitochondrialAll genesMitochondrialAll genesMitochondrialAll genes
Enriched in top 25 genes Enriched in top 50 genes Enriched in top 100 genes
NRF-2 induces SIRT3 expression, F. Kyle Satterstrom et al.820
ª 2015 The Authors. Aging Cell published by the Anatomical Society and John Wiley & Sons Ltd.
stress (e.g., Vassilopoulos et al., 2014). Thus, not only do NRF-2 and SIRT3
function in similar stress-induced pathways, but SIRT3 carries out
functions which are abrogated when NRF-2 is absent. Although whole-
body knockout of NRF-2 leads to embryonic lethality (Ristevski et al.,
2004), necessitating the use of tissue-specific deletion or other more
nuancedmethods, further study will determine whether NRF-2 is required
for the action of SIRT3 under basal and stressed conditions.
Our analysis additionally identified multiple transcription factors of
interest which may be involved in the regulation of SIRT3 expression.
CCAAT/enhancer-binding protein a (CEBPa), whose motif was enriched
in the neocortex dataset, and c-MYC, whose motif was enriched in the
kidney dataset, regulate metabolic processes and would be reasonable
candidate regulators of SIRT3. CEBPa regulates transcription of the
human fat mass and obesity-associated gene (FTO) (Ren et al., 2014),
and c-MYC is well known for its role in cancer metabolism (reviewed in
Miller et al., 2012). Additionally, our inspection of the SIRT3 promoter
identified binding sites for transcription factors known to interact with
NRF-2, including Sp1 and Sp3 (Galvagni et al., 2001), or share common
targets with it, including ZNF143 (Gerard et al., 2007) and EGR1 (Fromm
& Rhode, 2004). Finally, ETS-1, ELF-1, ELK1, and ELK4 are all members of
the same family of transcription factors as NRF-2. It is possible that one
or more was identified because of its similar binding motif without
actually playing a role in SIRT3 expression; it is also possible that they are
important in different contexts, or, when they are co-expressed, multiple
factors may bind the same promoter element to activate gene expression
with different strengths (Takahashi et al., 2008).
Our findings are an important step toward elucidating the molecular
regulation upstream of SIRT3 expression. SIRT3 levels are increased in
multiple tissues during nutrient stresses such as DR. DR is associated with
increased lifespan (Anderson & Weindruch, 2010), as is a SIRT3 allele
with increased activity (Bellizzi et al., 2005). We have shown that NRF-2
plays a role in the induction of SIRT3, and this may help to uncover the
molecular pathways activated by DR and to inform therapies that delay
the onset of age-related disease.
Experimental procedures
Analysis of SIRT3 levels in microarray datasets
Microarray series data and corresponding platform annotations from
DR/fasting experiments were downloaded from the Gene Expression
Omnibus at http://www.ncbi.nlm.nih.gov/geo/. Significance of the
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Fig. 2 Analysis of SIRT3 promoter. (A) List of transcription factor binding sites identified by MAPPER in the mouse SIRT3 promoter. (B) Overlap of enriched transcription
factor motifs identified by analysis of SIRT3 correlated genes in the neocortex dataset (pink circle) with transcription factors identified in the SIRT3 promoter (green circle).
(C) Schematic of PSMD13-SIRT3 promoter, highlighting tandem NRF-2 binding sites with red text/yellow background and showing sequence across multiple species.
Fig. 1 Bioinformatic identification of NRF-2 binding site enrichment in DNA sequences of SIRT3 and co-expressed genes. (A) Overview of bioinformatic steps analyzing
transcription factor binding motif enrichment in the DNA sequences of SIRT3 and co-expressed genes. (B) Top 25 most SIRT3-correlated genes (by Pearson’s r) in the mouse
neocortex dataset. (C) Enrichment of selected gene ontology terms in top 50 most SIRT3-correlated genes in neocortex (full results in Table S2, Supporting information).
(D–F) Heat maps of transcription factor motif enrichment in the (D) 25 most SIRT3-correlated genes, (E) 50 most SIRT3-correlated genes, and (F) 100 most SIRT3-correlated
genes (by expression levels across samples) for the neocortex dataset. All genes = most SIRT3-correlated genes analyzed from all genes in dataset. Mitochondrial = most
SIRT3-correlated mitochondrial genes analyzed in the dataset. Top ten motifs are shown, ordered by motif’s maximum AUC score, a measure of enrichment. Red = greater
enrichment; white = less enrichment. * indicates q < 0.05; ** indicates q < 0.01. (G) Overlap of significantly enriched transcription factor motifs identified in (D–F), showing
results from analyzing the 25 (red circle), 50 (blue circle), and 100 (yellow circle) most SIRT3-correlated genes for the neocortex dataset.
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are highlightedwith a yellowbackground. (K) Relative luminescence fromSIRT3 promoter reporterwithwild-type sequence (NRF-2wt),mutatedNRF-2 binding sites (NRF-2DM),
or deleted NRF-2 binding sites (NRF-2 DEL). (L) Chromatin immunoprecipitation of HA tag in 293T cells following the overexpression of NRF-2a-HA, showing percent input
(relative tob-actin) of SIRT3 andpositive (mTERF, POLRMT, TFB2M) andnegative (mTERF3, RPL30)NRF-2 controls. (M)Chromatin immunoprecipitation of histoneH3 in 293T cells
following the overexpression of NRF-2a-HA, showing percent input (relative to b-actin) of SIRT3 and positive and negative NRF-2 controls. For A–G, n = 3 samples per condition,
and B2Mwas used as the reference gene; for H–K,n = 4 samples per condition; for L andM, n = 3 separate immunoprecipitations; and for all, bars are standard error. * indicates
P < 0.05; ** indicates P < 0.01; and *** indicates P < 0.001. Two-tailed Student’s t-test was used for P values.
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effect on SIRT3 was determined using a two-tailed Student’s t-test
with a significance threshold of P < 0.05. In cases where the platform
had more than one probe for SIRT3, each probe was examined
individually.
Gene set enrichment analysis
Gene set enrichment analysis of each dataset showing a significant
induction of SIRT3 by DR/fasting was performed using the GSEA version
2.0.10 java program from http://www.broadinstitute.org/gsea/down-
loads.jsp. Data files were prepared with the Broad GEOImporter
preprocess utility and were analyzed for the enrichment of gene
ontology-related gene sets as contained in the c5.all.v3.1.symbols.gmt
gene sets database. Datasets were collapsed from probes to gene
symbols using default settings, and 1000 permutations were conducted.
Gene set permutations were used because none of the datasets had a
sufficient number of samples per condition to allow the use of
phenotype permutations. Datasets which showed no significant induc-
tion of any gene sets were not included in subsequent analysis.
Calculation of co-regulated gene sets
The robust multiarray average (RMA) algorithm as implemented in the
Bioconductor package ‘affy’ (Gautier et al., 2004) for R was used to
background adjust and normalize the raw data files for each dataset that
showed upregulation of Sirt3 and gene ontology-related gene sets upon
DR (except for GSE24504, for which the GEO series matrix was used).
Correlations (Pearson’s r) were then computed between the SIRT3 probe
and each probe in the array. To control for probe specificity, probes
whose label contained an _s_ or _x_ were removed from datasets
generated from the Affymetrix Mouse Genome 430 2.0 Array unless
doing so would leave the gene without any valid probes. For genes with
multiple probes, correlations were averaged to compute a single
correlation value for the gene.
Gene ontology analysis
Analysis of overrepresented gene ontology terms was carried out within
the Cytoscape software program using the BiNGO plugin (Maere et al.,
2005), with the whole mus musculus annotation as the reference set.
The hypergeometric statistical test and Benjamini & Hochberg FDR
correction options were used.
DNA sequence analysis
Analysis was conducted using the PhylCRM-Lever algorithm (Warner
et al., 2008). The sequence analysis looked at 20 kbp for each gene,
from 10 kbp to +10 kbp surrounding the transcription start site.
Motif enrichment was calculated for all 130 mammalian motifs hosted
by version 4 of the JASPAR database (Portales-Casamar et al., 2010;
http://jaspar.genereg.net/). The analysis included weighting based on
the conservation of transcription factor motifs across genomes of
multiple species: mouse (mm9), rat (rn4), human (hg18), chimpanzee
(panTro2), rhesus macaque (rheMac2), cow (bosTau3), dog (canFam2),
and chicken (galGal3). SIRT3 itself was included in the lists of SIRT3-
correlated genes.
Additional DNA sequence analysis was performed using MAPPER
(Marinescu et al., 2005). MAPPER database runs with default filtering
options examined 2 kbp of mus musculus DNA sequence upstream of
the transcription start, using TRANSFAC, MAPPER, and JASPAR models.
Cell culture
Human embryonic kidney 293T cells were grown in Dulbecco’s modified
Eagle’s minimal essential medium (Life Technologies, cat. # 11995) with
10% fetal bovine serum (HyClone GE Healthcare, Little Chalfont,
Buckinghamshire, United Kingdom) and 1% penicillin–streptomycin
supplement (Life Technologies, Carlsbad, CA, USA) and maintained in an
incubator at standard tissue culture conditions (37 °C, 5% CO2). A
control knockdown line was created using a GFP shRNA construct, and a
293T NRF-2a knockdown cell line was created using shRNA construct
TRCN0000235698 from the RNAi consortium (both via the Dana-Farber/
Harvard Cancer Center RNAi Core facility).
Expression and reporter plasmids
HA-tagged overexpression plasmids for NRF-2a and NRF-2b1 were
generated using Gateway cloning techniques, starting from the
HsCD00080063 and HsCD00370955 entry clones, respectively, from
the PlasmID database of the Dana-Farber/Harvard Cancer Center DNA
Resource Core. Untagged overexpression plasmids were generated via
Gateway cloning techniques from HsCD00296808 and HsCD00338810.
The reversible SIRT3-PSMD13 promoter reporter construct was cloned as
described (Satterstrom & Haigis, 2014). Plasmid DNA was transfected
into 293T cells using FuGene6 (Roche, Basel, Switzerland) according to
the manufacturer’s instructions, and cells were allowed to grow for 48 h
prior to analysis.
SIRT3 promoter reporter mutagenesis
SIRT3 promoter reporter mutants were cloned with altered NRF-2
binding sites (a change of two bases in each of the two binding sites) or
with deleted NRF-2 binding sites (both binding sites and the intervening
sequence removed, a total of 26 bases). A QuikChange II mutagenesis kit
(Agilent Technologies, Santa Clara, CA) was used to produce the mutant
with altered binding sites, in which both NRF-2 binding sites have a
mutation of CCGGAA to CCTTAA (Virbasius et al., 1993). To produce
the mutant with both binding sites deleted, a Q5 Site-Directed
Mutagenesis Kit (New England Biolabs, Ipswich, MA, USA) was used
with an annealing temperature of 72 °C. Primers used are given in Table
S3 (Supporting information). For the altered binding site mutant, the pair
labeled DM1 was used prior to the pair labeled DM2.
Luciferase
Cells were grown in an opaque 96-well plate. Following co-transfection
of the SIRT3 reporter plasmid and the pRL renilla control vector
(Promega, Madison, WI, USA), the Dual-Luciferase Reporter Assay
System (Promega) was used according to the manufacturer’s instruc-
tions. Sample luminescence was assayed with a Cary Varian Eclipse
fluorescence spectrophotometer.
Chromatin immunoprecipitation
Chromatin immunoprecipitation (ChIP) was performed with the Simple-
ChIP Enzymatic Chromatin IP Kit (Cell Signaling, Danvers, MA, USA) with
antibodies against HA tag (Cell Signaling), histone H3 (Cell Signaling), or
normal rabbit IgG (Cell Signaling). Relative quantities of precipitated
DNA fragments were obtained using quantitative PCR. Three separate
immunoprecipitations were performed. To control for variation in
percent input across precipitations, the percent input of each target
NRF-2 induces SIRT3 expression, F. Kyle Satterstrom et al. 823
ª 2015 The Authors. Aging Cell published by the Anatomical Society and John Wiley & Sons Ltd.
gene was divided by the percent input of a random background gene, b-
actin. These normalized values were then averaged across precipitations
and analyzed for significance.
Quantitative PCR
For overexpression experiments in cells, RNA was extracted using RNEasy
Mini Kits (Qiagen, Hilden, Germany) and cDNA was synthesized using
iScript cDNA Synthesis Kits (Bio-Rad, Hercules, CA, USA). For both
overexpression experiments and ChIP analysis, quantitative PCR was
performed with 29 PerfeCTa SYBR Green FastMix (Quanta BioSciences,
Gaithersburg, MD, USA). Control primers for ChIP analysis were from
Bruni et al. (2010); other primer sequences are given in Table S3
(Supporting information) (except RPL30; Cell Signaling). For non-ChIP
analysis, b2-microglobulin (B2M) was used as a reference gene.
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Fig. S1 Heat maps of transcription factor motif enrichment in DNA sequences
of SIRT3 and co-expressed genes for cochlea (A–C), liver (D–F), and kidney
(G–I) datasets based on sequence analysis of the top 25, 50, and 100 SIRT3-
correlated genes in each dataset.
Fig. S2 Effect of DR or fasting on NRF-2 and its target genes, including ERRa,
in the datasets used in this study (neocortex, GSE11291; cochlea, GSE4786;
liver, GSE26267, kidney, GSE24504) as well as a mouse dataset previously
generated by our laboratory (GSE34773, skeletal muscle).
Table S1 Gene set enrichment analysis summary for datasets with significant
induction of SIRT3 in mouse tissue by dietary restriction or fasting.
Table S2 Overrepresented gene ontology terms in the top 50 SIRT3-
correlated genes in each of the four datasets analyzed.
Table S3 Sequences of primers used in this study.
File S1 Complete correlations with SIRT3 expression for each gene in each of
four datasets analyzed.
File S2 All input gene groups used in PhylCRM-Lever DNA sequence analysis
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